Health IT

As the world grapples with drug-resistant bacteria, an Israeli biotech is testing a novel drug that physically destroys pathogens. Can it turn the tide?

Finland's capital is inviting firms to its '90 Hour Helsinki' program, offering a fast-track to top R&D clusters without the heavy upfront investment.

As corporate interests reshape medicine, a leading physician's call for stewardship revives a debate on the soul of healthcare. Can timeless values survive?

A new report shows California's self-insured employers face a puzzling trend: workers' comp claims are at a 5-year low, yet costs are surging. Why?

A new integration aims to make enterprise AI trustworthy by teaching it business context, transforming messy unstructured data into a strategic asset.

Intended to heal, some Physician Health Programs are accused of using flawed science and financial coercion to ruin careers. Are they a safety net or a trap?

A call for research on vaccine side effects exposes a deeper crisis: the collapse of public trust in science. Can rigorous data heal a polarized nation?

Bluejay Diagnostics secures critical funding to advance its rapid sepsis test, extending its cash runway but raising questions about shareholder dilution.

Alani Skin MD's "Best Med Spa" award reveals more than local popularity; it's a masterclass in leveraging market trends and customer loyalty.

A pivotal partnership between WeInfuse and Trial IQ leverages AI to bring clinical trials to local infusion centers, signaling a major shift in drug development.

NexTel Medical acquires two telehealth firms for an instant $135K in monthly revenue, aiming to launch its Maxasome™ exosome therapies to 1,850 clinics.

As Rise Therapeutics advances its oral drug R-2487, it’s not just developing another pill. It’s testing a radical new idea: resetting the immune system.

A new study reveals an 'early warning system' in infant guts, offering a window to combat the atopic march before allergies take hold. Is this the future?

Mindray's new Hepatus-Series goes beyond a simple product launch, integrating AI-driven elastography to transform GI diagnostics and challenging market norms.

As psychedelics go mainstream, a new initiative asks a hard question: what about those most harmed by their prohibition? MAPS' latest project is a radical rethink.

The new venture, Integron Systems, aims to tackle construction's biggest challenges with offsite fabrication, targeting high-growth sectors like data centers.

By turning 2,792 miles of GPS data into a stop-motion film, a nonprofit is redefining advocacy and inviting the world to run for a cause.

A delayed financial report and a plea for a trading halt for its own executives place Premier Health under a harsh spotlight, signaling deeper financial distress.

A burgeoning market for cervical dystonia is set for disruption. A pipeline of novel therapies, including oral options, promises to address unmet patient needs.

With AI poised to dominate enterprise communication, a startup's $10M seed round bets its 'pre-send' firewall can solve a $2.2 billion regulatory headache.